| A three-tiered approach to address barriers to COVID-19 vaccine delivery in the Black community JC Abdul-Mutakabbir, S Casey, V Jews, A King, K Simmons, MD Hogue, ... The Lancet Global Health 9 (6), e749-e750, 2021 | 89 | 2021 |
| Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study SCJ Jorgensen, EJ Zasowski, TD Trinh, AM Lagnf, S Bhatia, N Sabagha, ... Clinical Infectious Diseases 71 (1), 1-10, 2020 | 76 | 2020 |
| Evaluation of eravacycline: a novel fluorocycline S Alosaimy, JC Abdul‐Mutakabbir, R Kebriaei, SCJ Jorgensen, MJ Rybak Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (3 …, 2020 | 46 | 2020 |
| Addressing and inspiring vaccine confidence in black, indigenous, and people of color during the coronavirus disease 2019 pandemic JR Marcelin, TH Swartz, F Bernice, V Berthaud, R Christian, C Da Costa, ... Open forum infectious diseases 8 (9), ofab417, 2021 | 43 | 2021 |
| Cefiderocol: a novel Siderophore cephalosporin against multidrug‐resistant gram‐negative pathogens JC Abdul‐Mutakabbir, S Alosaimy, T Morrisette, R Kebriaei, MJ Rybak Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (12 …, 2020 | 41 | 2020 |
| Bacteriophage-antibiotic combination strategy: an alternative against methicillin-resistant phenotypes of Staphylococcus aureus R Kebriaei, K Lev, T Morrisette, KC Stamper, JC Abdul-Mutakabbir, ... Antimicrobial agents and chemotherapy 64 (7), 10.1128/aac. 00461-20, 2020 | 40 | 2020 |
| In Vitro Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumannii JC Abdul-Mutakabbir, L Nguyen, PT Maassen, KC Stamper, R Kebriaei, ... Antimicrobial agents and chemotherapy 65 (9), 10.1128/aac. 02646-20, 2021 | 36 | 2021 |
| Contemporary Perspective on the Treatment of Acinetobacter baumannii Infections: Insights from the Society of Infectious Diseases Pharmacists JC Abdul-Mutakabbir, NC Griffith, RK Shields, FP Tverdek, ZK Escobar Infectious diseases and therapy, 1-26, 2021 | 33 | 2021 |
| Community-academic partnerships to reduce COVID-19 vaccine hesitancy in minoritized communities B Peteet, JC Belliard, J Abdul-Mutakabbir, S Casey, K Simmons EClinicalMedicine 34, 2021 | 33 | 2021 |
| Bacteriophage-antibiotic combinations for Enterococcus faecium with varying bacteriophage and daptomycin susceptibilities T Morrisette, KL Lev, R Kebriaei, JC Abdul-Mutakabbir, KC Stamper, ... Antimicrobial agents and chemotherapy 64 (9), 10.1128/aac. 00993-20, 2020 | 31 | 2020 |
| Teaching an old class new tricks: a novel semi-synthetic aminoglycoside, plazomicin JC Abdul-Mutakabbir, R Kebriaei, SCJ Jorgensen, MJ Rybak Infectious Diseases and Therapy 8, 155-170, 2019 | 29 | 2019 |
| Gender inequity and sexual harassment in the pharmacy profession: evidence and call to action BD Bissell, JP Johnston, RR Smith, AS Newsome, ML Thompson Bastin, ... American Journal of Health-System Pharmacy 78 (22), 2059-2076, 2021 | 28 | 2021 |
| Predictors of COVID-19 vaccine acceptance and hesitancy among healthcare workers in Southern California: not just “anti” vs.“pro” vaccine A Dubov, BJ Distelberg, JC Abdul-Mutakabbir, WL Beeson, LK Loo, ... Vaccines 9 (12), 1428, 2021 | 27 | 2021 |
| The evolving reduction of vancomycin and daptomycin susceptibility in MRSA—salvaging the gold standards with combination therapy T Morrisette, S Alosaimy, JC Abdul-Mutakabbir, R Kebriaei, MJ Rybak Antibiotics 9 (11), 762, 2020 | 24 | 2020 |
| In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii JC Abdul-Mutakabbir, J Yim, L Nguyen, PT Maassen, K Stamper, ... Antibiotics 10 (7), 880, 2021 | 21 | 2021 |
| Faith, fear, and facts: A COVID-19 vaccination hesitancy intervention for black church congregations B Peteet, V Watts, E Tucker, P Brown, M Hanna, A Saddlemire, M Rizk, ... Vaccines 10 (7), 1039, 2022 | 16 | 2022 |
| Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of Staphylococcus aureus in a Pharmacokinetic … JC Abdul-Mutakabbir, R Kebriaei, KC Stamper, Z Sheikh, PT Maassen, ... Antibiotics 9 (10), 696, 2020 | 13 | 2020 |
| Social media: flattening hierarchies for women and black, indigenous, people of color (BIPOC) to enter the room where it happens BK Titanji, JC Abdul-Mutakabbir, B Christophers, L Flores, JR Marcelin, ... Clinical Infectious Diseases 74 (Supplement_3), S222-S228, 2022 | 12 | 2022 |
| International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for … LT Hong, KJ Downes, A FakhriRavari, JC Abdul‐Mutakabbir, JL Kuti, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 43 (8 …, 2023 | 11 | 2023 |
| Rapid implementation of a community–academic partnership model to promote COVID-19 vaccine equity within racially and ethnically minoritized communities JC Abdul-Mutakabbir, C Granillo, B Peteet, A Dubov, SB Montgomery, ... Vaccines 10 (8), 1364, 2022 | 11 | 2022 |
